High-Sensitivity Cardiac Troponin I and B-Type Natriuretic Peptide as Predictors of Vascular Events in Primary Prevention

Supplement Table 1. Baseline characteristics of the subcohort with samples assayed for high-­‐sensitivity troponin I compared to the remainder of the JUPITER cohort Supplement Table 2. Baseline characteristics of the study population stratified by B-­‐type natriuretic peptide tertile Supplement Table 3. Spearman correlations of biomarkers in men enrolled in JUPITER Supplement Table 4. Spearman correlations of biomarkers in women enrolled in JUPITER Supplement Figure 1. Risk of the JUPITER primary endpoint according to baseline category of high sensitivity cardiac troponin I and B-­‐type natriuretic peptide stratified by random allocation to active rosuvastatin or placebo. Supplement Figure 2. Adjusted relative risk of a first major cardiovascular event, according to random allocation to rosuvastatin 20 mg versus placebo.